Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

746
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
746
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

451
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
451
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

469
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
469
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference Framework for Implementation of Cardiovascular Imaging in Clinical Trials. A Scientific Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC.

European heart journal. Cardiovascular Imaging·2026
Same author

Hyperthermia-Enhanced Adeno-Associated Virus Gene Therapy: Mechanisms, Delivery Technologies, and Translational Potential.

Human gene therapy·2026
Same author

Visual Right Ventricular Assessment in ICU: A Multicenter International Study.

Critical care medicine·2026
Same author

Contemporary surgical outcomes and repair rates in degenerative mitral regurgitation: Real-world insights from the international MITRACURE registry.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Optimal Method for Echocardiographic Right Ventricular Mass Estimation in Pulmonary Hypertension.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

New Approaches to Cardiac Gene Therapy Delivery.

The Canadian journal of cardiology·2026

Related Experiment Video

Updated: Feb 8, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

870

Chronic Pulmonary Artery Embolization Models in Large Animals.

Jaume Aguero1,2,3, Nadjib Hammoudi4, Olympia Bikou4

  • 1Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. jaimeaguero30@hotmail.com.

Methods in Molecular Biology (Clifton, N.J.)
|July 11, 2018
PubMed
Summary

Researchers developed a reproducible swine model for chronic thromboembolic pulmonary hypertension (CTEPH) using non-surgical embolizations. This model aids in evaluating new diagnostic tools and therapies for pulmonary vascular disease (PVD).

Keywords:
Large animal disease modelsPulmonary embolizationPulmonary hypertensionPulmonary vascular diseaseVascular remodeling

More Related Videos

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

851

Related Experiment Videos

Last Updated: Feb 8, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

870
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

3.4K
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
08:02

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots

Published on: October 25, 2024

851

Area of Science:

  • Cardiovascular Research
  • Pulmonary Vascular Disease Modeling
  • Preclinical Animal Studies

Background:

  • Pulmonary vascular disease (PVD) and pulmonary hypertension (PH) exhibit significant clinical heterogeneity.
  • Existing animal models for PH often fail to recapitulate specific disease phenotypes.
  • Chronic thromboembolic pulmonary hypertension (CTEPH), a prevalent form of PH, requires a well-established large animal model for preclinical research.

Purpose of the Study:

  • To describe a protocol for creating experimental CTEPH models in swine.
  • To establish a standardized framework for characterizing PH models, focusing on hemodynamics, right ventricular (RV) function, and PVD histology.
  • To facilitate the evaluation of novel diagnostic tools and therapeutic strategies for CTEPH.

Main Methods:

  • Utilized recurrent pulmonary embolizations of dextran microspheres in swine.
  • Employed non-surgical, fully percutaneous techniques for embolization.
  • Administered a minimum of four embolization procedures over a 1-2 month period.

Main Results:

  • Achieved mild to moderate PH hemodynamics (mean PA pressure increase of ~20-60%).
  • Induced severe pulmonary vascular remodeling with mild right ventricular (RV) remodeling.
  • Demonstrated high reproducibility and low mortality (<10%) in the model.

Conclusions:

  • The described protocol provides a reproducible, non-surgical method for creating a large animal model of CTEPH in swine.
  • This model effectively recapitulates key pathological features of CTEPH, including pulmonary vascular remodeling.
  • The standardized framework supports the preclinical evaluation of diagnostic and therapeutic interventions for CTEPH.